No Prescription |
 |
 | ||
|
Daktarin Oral Gel Generic Miconazole |
|
| ||
No Prescription » Prescription Drugs 5 » Daktarin Oral Gel Generic Miconazole DAKTARIN Oral Gel is used to treat infections of the mouth and throat (e.g. thrush).DAKTARIN Oral Gel is an antifungal. These medicines work by treating infections caused by fungi including yeast.When you must not use itDo not use DAKTARIN Oral Gel if you know you are allergic to any of the ingredients. (See the last section of this leaflet for a list of ingredients). Signs of allergy include a skin rash itching shortness of breath and/or a swollen face lips tongue or other parts of the body.Do not use DAKTARIN Oral Gel if you have liver disease. DAKTARIN Oral Gel could make the symptoms of your liver disease worse.Do not give DAKTARIN Oral Gel to an infant below the age of 6 months. The safety of this medicine in infants under 6 months of age has not been established.Do not use DAKTARIN Oral Gel if the packaging is torn or shows signs of tampering. Do not use DAKTARIN Oral Gel beyond the expiry date (month and year) printed on the pack. Buy Daktarin Oral Gel Generic Miconazole and other Prescription Drugs 5 products online at Medstore. Buy Online at Medstore - Click Here!
About Daktarin Oral Gel Generic Miconazole: Product Type: Prescription Drugs 5 Daktarin Oral Gel ( Generic Miconazole ) Daktarin Oral Gel (Generic Miconazole) Generic Miconazole 20mg/g 40gm 120gm(3 x 40gm) Generic Miconazole Daktarin Oral Gel
View more Prescription Drugs 5 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
